Results 91 to 100 of about 12,153 (191)
Purpose: A previous meta-analysis showed that the association between the UGT1A1*28 genotype and irinotecan-induced neutropenia was influenced by irinotecan dose and that the risk of neutropenia was similar at low doses for patients with all genotypes ...
Qi Yu, Cheng Guo, Qi Pei, Zhe-Yi Hu
core +1 more source
The role of UGT1A1 polymorphism in the management of colorectal cancer
Colorectal cancer is a leading cause of cancer related deaths among patients worldwide, necessitating the development of more effective and tolerable therapies. Topoisomerase I inhibitors such as Irinotecan are integral components of chemotherapy regimens used in the management of colorectal, as well as esophageal, gastric, biliary tract, pancreatic ...
Elham Babadi +3 more
openaire +3 more sources
Optimal dosing in pregnant and lactating women requires an understanding of the pharmacokinetics in the mother, fetus, and breastfed infant. Physiologically‐based pharmacokinetic (PBPK) modeling can be used to simulate untested scenarios and hence ...
Jia Ning +5 more
doaj +1 more source
Pre‐therapeutic UGT1A1 genotyping is increasingly performed in patients receiving irinotecan, as its active metabolite SN‐38 is primarily cleared through UGT1A1‐mediated glucuronidation.
Tessa Goedhart, Henk‐Jan Guchelaar
doaj +1 more source
ASSOCIATION OF UGT1A1 GLY71ARG WITH URINE UROBILINOGEN
Bilirubin is glucoronized by uridine diphosphate-glucuronosyl transferase 1A1 (UGT1A1) mainly in the liver, and excreted into bile. The conjugated form is metabolized into the unconjugated form, and then into urobilinogen by bacteria in the intestine ...
KATAOKA, RYUJI +12 more
core
Clinical Implications of <i>UGT1A1</i> Polymorphisms in Anticancer Therapy: An Updated Review. [PDF]
Vitale SR +8 more
europepmc +1 more source
Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer. [PDF]
Zhou C +10 more
europepmc +1 more source

